Hospital Costa Del Sol
- Address
- Terreno Autovia Mediterraneo A-7 S/n, 29603 Marbella, Spain
Cardiovascular Research
Hospital Costa Del Sol’s internal medicine team is leading studies in cardiovascular disease, targeting the primary prevention of atherosclerotic cardiovascular disease.
- Evaluation of a novel RNA‑based therapy to lower major adverse cardiac events
- Assessment of risk reduction in high‑risk primary prevention patients
- Investigation of long‑term safety and effectiveness of preventive treatment
The trials aim to demonstrate that new preventive strategies can lower the incidence of heart attacks, strokes, and related complications, offering safer options for patients at elevated cardiovascular risk.
Oncology Research
The site is also active in cancer research, focusing on chronic lymphocytic leukemia in patients who have not received prior therapy.
- Comparison of continuous ibrutinib monotherapy with fixed‑duration venetoclax‑based regimens
- Measurement of progression‑free survival as a primary outcome
- Exploration of treatment sequencing to improve long‑term disease control
These studies seek to identify the most effective treatment approach for newly diagnosed CLL, potentially reducing disease progression and enhancing quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Costa Del Sol
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab versus fixed-duration Venetoclax plus Ibrutinib in patients with previously untreated chronic lymphocytic leukaemia (CLL) - CLL17 | University Of Cologne | Phase III | Not Recruiting | Feb 2021 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ibrutinib | 1 | Unknown | 2021-02-11 | 2021-02-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.